Patients with unrecognized peripheral arterial disease (PAD) assessed by ankle-brachial index (ABI) present a defined profile of proinflammatory markers compared to healthy subjects

Cytokine

Volumn 59, Issue 2, 2012, Pages 294-298

  Signorelli, Salvatore Santo ^a   Anzaldi, Massimiliano ^a   Fiore, Valerio ^a   Simili, Massimo ^a   Puccia, Giuseppe ^a   Libra, Massimo ^a   Malaponte, Graziella ^a   Neri, Sergio ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

ABI; Atherosclerosis; Inflammatory markers; Metalloproteinases; Peripheral artery disease

Indexed keywords

BIOLOGICAL MARKER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GELATINASE A; GELATINASE B; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; ASYMPTOMATIC DISEASE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ANKLE BRACHIAL INDEX; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DEMOGRAPHY; E-SELECTIN; FEMALE; HEALTH; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE;

EID: 84862307246     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.04.038     Document Type: Article

References (45)

1. Fowkes F.G., Housley E., Cawood E.H., Macintyre C.C., Ruckley C.V., Prescott R.J. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991, 20:384-392.
2. Signorelli S., Anzaldi M., Fiore V., Catanzaro S., Simili M., Torrisi B., et al. Study on unrecognized peripheral arterial disease (PAD) by ankle/brachial index and arterial co-morbidity in Catania (Sicily, Italy). Angiology 2010, 61:524-529.
3. Criqui M.H., Langer R.D., Fronek A., Feigelson H.S. Coronary disease and stroke in patients with large-vessel peripheral arterial disease. Drugs 1991, 42(Suppl 5):16-21.
4. Criqui M.H., Langer R.D., Fronek A., et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992, 326:381-386.
5. Diehm C., Lange S., Darius H., et al. Association of low ankle brachial index with high mortality in primary care. Eur Heart J 2006, 27:1743-1749.
6. Resnick H.E., Lindsay R.S., McDermott M.M., et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation 2004, 109:733-739.
7. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-126.
8. Andreozzi G.M., Martini R., Cordova R., et al. Circulating levels of cytokines (IL-6 and IL-1beta) in patients with intermittent claudication, at rest, after maximal exercise treadmill test and during restore phase. Could they be progression markers of the disease?. Int Angiol 2007, 26:245-252.
9. Beckman J.A., Preis O., Ridker P.M., Gerhard-Herman M. Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death). Am J Cardiol 2005, 96:1374-1378.
10. Brevetti G., Martone V.D., de Cristofaro T., et al. High levels of adhesion molecules are associated with impaired endothelium-dependent vasodilation in patients with peripheral arterial disease. Thromb Haemost 2001, 85:63-66.
11. Murabito J.M., Keyes M.J., Guo C.Y., et al. Cross-sectional relations of multiple inflammatory biomarkers to peripheral arterial disease: The Framingham Offspring Study. Atherosclerosis 2009, 203:509-514.
12. Nylaende M., Kroese A., Stranden E., et al. Markers of vascular inflammation are associated with the extent of atherosclerosis assessed as angiographic score and treadmill walking distances in patients with peripheral arterial occlusive disease. Vasc Med 2006, 11:21-28.
13. Mukherjee D., Cho L. Peripheral arterial disease: considerations in risks, diagnosis, and treatment. J Natl Med Assoc 2009 Oct, 101(10):999-1008.
14. Potier L., Abi Khalil C., Mohammedi K., Roussel R. Use and utility of ankle brachial index in patients with diabetes. Eur J Vasc Endovasc Surg 2011 Jan, 41(1):110-116.
15. Zhou W., Chai H., Ding R., Lam H.Y. Distribution of inflammatory mediators in carotid and femoral plaques. J Am coll Surg 2010, 211(1):92-98.
16. Ho K.S., Spite M., Owens C.D., Lancero H., Kroemer A.H., Pande R., et al. Asprin-triggered lipoxin and resovin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis. Am J Pathol 2010, 177(4):2116-2123.
17. Silvestro A., Scopacasa F., Ruocco A., Oliva G., Schiano V., Zincarelli C., et al. Inflammatory status and endothelial function in asymptomatic and symptomatic peripheral arterial disease. Vasc Med 2003 Nov, 8(4):225-232.
18. Brevetti G., Silvestro A., Di Giacomo S., et al. Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden. J Vasc Surg 2003, 38:374-379.
19. Abeywardena M.Y., Leifert W.R., Warnes K.E., Varghese J.N., Head R.J. Cardiovascular biology of interleukin-6. Curr Pharm Des 2009, 15(15):1809-1821.
20. Haddy N., Sass C., Droesch S., et al. IL-6, TNF-alpha and atherosclerosis risk indicators in a healthy family population: the STANISLAS cohort. Atherosclerosis 2003, 170:277-283.
21. Klouche M., Rose-John S., Schmiedt W., Bhakdi S. Enzymatically degraded, nonoxidized LDL induces human vascular smooth muscle cell activation, foam cell transformation, and proliferation. Circulation 2000, 101:1799-1805.
22. Cooke J.P., Wilson A.M. Biomarkers of peripheral arterial disease. J Am Coll Cardiol 2010 May 11, 55(19):2017-2023.
23. Tzoulaki I., Murray G.D., Lee A.J., Rumley A., Lowe G.D., Fowkes F.G. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation 2005, 112:976-983.
24. McDermott M.M., Guralnik J.M., Corsi A., et al. Patterns of inflammation associated with peripheral arterial disease: the InCHIANTI study. Am Heart J 2005, 150:276-281.
25. Libra M., Signorelli S.S., Bevelacqua Y., et al. Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease. J Clin Pathol 2006, 59:211-215.
26. Metcalfe J.C., Grainger D.J. Transforming growth factor-beta and the protection from cardiovascular injury hypothesis. Biochem Soc Trans 1995, 23:403-406.
27. Li M.O., Sanjabi S., Flavell R.A. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 2006, 25:455-471.
28. + regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants. J Immunol 2004, 172:6003-6010.
29. Kulkarni A.B., Karlsson S. Transforming growth factor-beta 1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease. Am J Pathol 1993, 143:3-9.
30. Grainger D.J. Transforming growth factor beta and atherosclerosis: so far, so good for the protective cytokine hypothesis. Arterioscler Thromb Vasc Biol 2004, 24:399-404.
31. Yamagami S., Yokoo S., Mimura T., Amano S. Effects of TGF-beta2 on immune response-related gene expression profiles in the human corneal endothelium. Invest Ophthalmol Vis Sci 2004, 45:515-521.
32. Lutgens E., Gijbels M., Smook M., et al. Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression. Arterioscler Thromb Vasc Biol 2002, 22:975-982.
33. Leeuwenberg J.F., Smeets E.F., Neefjes J.J., et al. E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. Immunology 1992, 77:543-549.
34. Meredith I.T., Plunkett J.C., Worthley S.G., Hope S.A., Cameron J.D. Systemic inflammatory markers in acute coronary syndrome: association with cardiovascular risk factors and effect of early lipid lowering. Coron Artery Dis 2005 Nov, 16(7):415-422.
35. Miwa K., Igawa A., Inoue H. Soluble E-selectin, ICAM-1 and VCAM-1 levels in systemic and coronary circulation in patients with variant angina. Cardiovasc Res 1997, 36:37-44.
36. Signorelli S.S., Malaponte G., Libra M., et al. Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type II diabetics with peripheral arterial disease. Vasc Med 2005, 10:1-6.
37. Borkakoti N. Structural studies of matrix metalloproteinases. J Mol Med 2000, 78:261-268.
38. Zucker S., Doshi K., Cao J. Measurement of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMP) in blood and urine: potential clinical applications. Adv Clin Chem 2004, 38:37-85.
39. Santos-Martínez M.J., Medina C., Jurasz P., Radomski M.W. Role of metalloproteinases in platelet function. Thromb Res 2008, 121(4):535-542.
40. Visse R., Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003, 92:827-839.
41. Galis Z.S., Johnson C., Godin D., et al. Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ Res 2002, 91:852-859.
42. Busti C., Falcinelli E., Momi S., Gresele P. Matrix metalloproteinases and peripheral arterial disease. Int Emerg Med 2010 Feb, 5(1):13-25.
43. Shah P.K., Galis Z.S. Matrix metalloproteinase hypothesis of plaque rupture: players keep piling up but questions remain. Circulation 2001, 104:1878-1880.
44. Saetre T., Enoksen E., Lyberg T., Stranden E., Jorgersen J.J., Sundhagen J.O., et al. Supervised exercise training reduces plasma levels of the endothelial inflammatory markers E-selectin and ICAM-1 in patients with peripheral arterial disease. Angiology 2011, 62(4):301-305.
45. Jovilano E.E., Piccinato C.E., Dellalibera-Jovilano R., Moryia T., Evora P.R., et al. Inflammatory markers and restenosis in peripheral percutaneous angioplasty with intravascular stentintg: current concepts. Ann Vasc Surg 2011, 25(6):846-855.